[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342539-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342539-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","detailed-characterization-of-the-lung-gut-microbiome-axis-reveals-the-link-between-pd-l1-and-the-microbiome-in-non-small-cell-lung-cancer-patients","Detailed Characterization of the Lung-Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients","","Next-generation sequencing reshapes respiratory research by enabling high-resolution profiling of microbiomes in health and malignancy. This study targets the lung–gut axis in non-small-cell lung cancer (NSCLC) patients, focusing on how lung–gut microbiota relates to clinical parameters including CRP, NLR, LPS, CD8, and PD-L1. Lung tissue and fecal samples underwent bacterial 16S rRNA sequencing. Bacterial richness in lung tumor tissue decreased with increasing PD-L1 expression, with significant genus-level correlations (Romboutsia and Alistipes) and improved overall survival in patients with higher stool richness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/detailed-characterization-of-the-lung-gut-microbiome-axis-reveals-the-link-between-pd-l1-and-the-microbiome-in-non-small-cell-lung-cancer-patients/342539/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/detailed-characterization-of-the-lung-gut-microbiome-axis-reveals-the-link-between-pd-l1-and-the-microbiome-in-non-small-cell-lung-cancer-patients/342539.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal in NSCLC patients?","Question",{"text":63,"@type":64},"To explore the lung–gut axis in non-small-cell lung cancer patients and assess associations between lung–gut axis microbiota and clinical parameters such as CRP, NLR, LPS, CD8, and PD-L1.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the microbiome samples analyzed?",{"text":68,"@type":64},"Lung tissue and fecal samples were analyzed using bacterial 16S rRNA sequencing to characterize the lung and gut microbiota.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationships were found between PD-L1 and lung tumor microbiota?",{"text":72,"@type":64},"Bacterial richness in lung tumor tissue gradually decreased as PD-L1 expression increased, and the correlation analysis highlighted significant genus-level associations, including Romboutsia and Alistipes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342539,1790816020,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Article  \nDetailed Characterization of the Lung–Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients  \nVytautas Ankudavicius 1, *,†, Darja Nikitina 2,†, Rokas Lukosevicius 2, Deimante Tilinde 2, Violeta Salteniene 2, Lina Poskiene 3, Skaidrius Miliauskas 1, Jurgita Skieceviciene 2, Marius Zemaitis 1,‡ and Juozas Kupcinskas 2,4,‡  \nCitation: Ankudavicius, V.; Nikitina, D.; Lukosevicius, R.; Tilinde, D.; Salteniene, V.; Poskiene, L.;  \nMiliauskas, S.; Skieceviciene, J.; Zemaitis, M.; Kupcinskas, J. Detailed Characterization of the Lung–Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients. Int. J. Mol. Sci. 2024, 25, 2323. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25042323  \nAcademic Editors: Simon McArthur and Mariusz Chabowski  \nReceived: 11 December 2023  \nRevised: 26 January 2024  \nAccepted: 9 February 2024  \nPublished: 15 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Pulmonology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania  \n2 Institute for Digestive Research, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania  \n3 Department of Pathology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania  \n4 Department of Gastroenterology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania  \n* [Correspondence: vytautas.ankudavicius@lsmu.lt](Correspondence: vytautas.ankudavicius@lsmu.lt)[ ](Correspondence: vytautas.ankudavicius@lsmu.lt)† These authors contributed equally to this work.  \n‡ These authors also contributed equally to this work.  \nAbstract: Next-generation sequencing technologies have started a new era of respiratory tract research in recent years. Alterations in the respiratory microbiome between healthy and malignant conditions have been revealed. However, the composition of the microbiome varies among studies, even in similar medical conditions. Also, there is a lack of complete knowledge about lung–gut microbiome interactions in lung cancer patients. The aim of this study was to explore the lung–gut axis in non-small-cell lung cancer (NSCLC) patients and the associations between lung–gut axis microbiota and clinical parameters (CRP, NLR, LPS, CD8, and PD-L1) . Lung tissue and fecal samples were used for bacterial 16S rRNA sequencing. The results revealed, for the ﬁrst time, that the bacterial richness in lung tumor tissue gradually decreased with an increase in the level of PD-L1 expression (p \u003C 0.05) . An analysis of 􀀌-diversity indicated a signiﬁcant positive correlation between the genera Romboutsia and Alistipes in both the lung tumor biopsies and stool samples from NSCLC patients (p \u003C 0.05) . Survival analysis showed that NSCLC patients with higher bacterial richness in their stool samples had prolonged overall survival (HR: 2.06, 95% CI: 1.025–4.17, p = 0.0426) .  \nKeywords: lung cancer; lung–gut axis; microbiota; PD-L1  \n1. Introduction  \nThe human microbiome is composed of thousands of bacterial species that colonize the gut, skin, oral cavity, urinary tract, and reproductive system [1,2] . Our microbiome is shaped by multiple factors, including diet, the environment, antibiotics, and other factors [3] . Multiple studies have suggested that deregulation of the human microbiome may contribute to the development of various complex diseases, including cancer [4–9] .  \nFor a long time, the lungs were considered sterile organs until culture-independent technologies revealed that they are inhabited by diverse microbial communities [10] . Early reports bas","cbCainMKSDiX5oZW","https://ap.wps.com/l/cbCainMKSDiX5oZW","pdf",4876572,18,"English","# Abstract\n# Introduction\n## Microbiome background and lung sterility\n## Treatment context and PD-L1 links\n## Tumor microenvironment and immune checkpoints","[{\"question\":\"What was the study’s main goal in NSCLC patients?\",\"answer\":\"To explore the lung–gut axis in non-small-cell lung cancer patients and assess associations between lung–gut axis microbiota and clinical parameters such as CRP, NLR, LPS, CD8, and PD-L1.\"},{\"question\":\"How were the microbiome samples analyzed?\",\"answer\":\"Lung tissue and fecal samples were analyzed using bacterial 16S rRNA sequencing to characterize the lung and gut microbiota.\"},{\"question\":\"What relationships were found between PD-L1 and lung tumor microbiota?\",\"answer\":\"Bacterial richness in lung tumor tissue gradually decreased as PD-L1 expression increased, and the correlation analysis highlighted significant genus-level associations, including Romboutsia and Alistipes.\"}]","Detailed Characterization of the Lung-Gut Microbiome Axis Reveals the Link between PD-L1 and the Microbiome in Non-Small-Cell Lung Cancer Patients | PDF",1790047043,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd1ca098fd612c599d951f613bd1bf2c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/869fcc6836311ca5af2c23b26811ae5b.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6423e4c97b8587b62589ffc6e7460692.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66c1eff7081b5203733ffe519d9cfba4.webp",980,1385]